Insider · CIK 0001538894

Daniel Thomas O

Reports to the SEC for 6 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001538894

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2026-06-04	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+115K sh	—	—	115,000
2025-06-25	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+115K sh	—	—	115,000
2024-06-06	GOSSGossamer Bio, Inc. · Non-qualified stock option (Right to Buy)A Award	Director	AAward	+115K sh	—	—	115,000
2023-06-08	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2022-06-28	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-06-09	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-06-09	GOSSGossamer Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2021-06-01	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+18.2K sh	—	—	18,188
2021-05-12	LRMRLarimar Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,300 sh	—	—	8,300
2020-09-29	LRMRLarimar Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.6K sh	—	—	16,600
2020-06-17	GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2020-06-05	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+18.2K sh	—	—	18,188
2019-06-26	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2019-06-10	GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2019-06-07	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+18.2K sh	—	—	18,188
2019-02-12	GOSSGossamer Bio, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−171K sh	—	—	0
2019-02-12	GOSSGossamer Bio, Inc.C Conversion	Director	CConversion	+38.1K sh	—	—	38,095
2019-01-24	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.3K sh	—	—	13,280
2018-06-25	DNTHDianthus Therapeutics, Inc. /DE/ · Series B Preferred StockC Conversion	Director	CConversion	−30K sh	—	—	0
2018-06-25	DNTHDianthus Therapeutics, Inc. /DE/ · Series A Preferred StockC Conversion	Director	CConversion	−33.4K sh	—	—	0
2018-06-25	DNTHDianthus Therapeutics, Inc. /DE/C Conversion	Director	CConversion	+24.5K sh	—	—	101,926
2018-06-06	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-03-05	Juno Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$63.71	−$765K	0
2018-01-03	LRMRLarimar Therapeutics, Inc.A Award	Director	AAward	+8,687 sh	$5.18	+$45K	19,452
2017-06-21	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2017-06-16	Juno Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2017-02-13	LRMRLarimar Therapeutics, Inc.A Award	Director	AAward	+10.8K sh	$4.18	+$45K	10,765
2016-06-30	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2016-04-01	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,841 sh	—	—	3,841
2016-04-01	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2015-12-23	CELGENE CORP /DE/G Gift	see remarks	GGift	−15.8K sh	—	—	49,972
2015-12-17	CELGENE CORP /DE/Restricted Stock UnitM Exercise/Conversion	see remarks	MExercise/Conversion	−7,500 sh	—	—	7,500
2015-12-17	CELGENE CORP /DE/F Tax Payment	see remarks	FTax Payment	−3,913 sh	$112.17	−$439K	65,765
2015-12-17	CELGENE CORP /DE/M Exercise/Conversion	see remarks	MExercise/Conversion	+7,500 sh	—	—	69,678
2015-12-16	CELGENE CORP /DE/Restricted Stock UnitA Award	see remarks	AAward	+7,143 sh	—	—	7,143
2015-11-09	CELGENE CORP /DE/Stock Option (right to buy)A Award	see remarks	AAward	+8,625 sh	—	—	8,625
2015-08-10	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	see remarks	MExercise/Conversion	−8,334 sh	—	—	2,000
2015-08-10	CELGENE CORP /DE/S Sale	see remarks	SSale	−25.6K sh	$130.82	−$3.35M	62,178
2015-08-10	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	see remarks	MExercise/Conversion	−17.2K sh	—	—	0
2015-08-10	CELGENE CORP /DE/M Exercise/Conversion	see remarks	MExercise/Conversion	+17.2K sh	$36.96	+$637K	79,422
2015-08-10	CELGENE CORP /DE/M Exercise/Conversion	see remarks	MExercise/Conversion	+8,334 sh	$29.75	+$248K	87,756
2015-07-28	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	see remarks	MExercise/Conversion	−2,292 sh	—	—	0
2015-07-28	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	see remarks	MExercise/Conversion	−15K sh	—	—	0
2015-07-28	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	see remarks	MExercise/Conversion	−13K sh	—	—	10,334
2015-07-28	CELGENE CORP /DE/Stock Option (right to buy)M Exercise/Conversion	see remarks	MExercise/Conversion	−1,720 sh	—	—	0
2015-07-28	CELGENE CORP /DE/M Exercise/Conversion	see remarks	MExercise/Conversion	+1,720 sh	$25.77	+$44.3K	61,050
2015-07-28	CELGENE CORP /DE/M Exercise/Conversion	see remarks	MExercise/Conversion	+1,128 sh	$30.74	+$34.7K	62,178
2015-07-28	CELGENE CORP /DE/M Exercise/Conversion	see remarks	MExercise/Conversion	+1,506 sh	$36.96	+$55.7K	59,330
2015-07-28	CELGENE CORP /DE/M Exercise/Conversion	see remarks	MExercise/Conversion	+2,292 sh	$28.50	+$65.3K	57,824

Recent filings

Accepted (ET)
Sep 254
Daniel Thomas O0001628280-26-063619
SEC(opens sec.gov)
Jun 54
Daniel Thomas O0001538894-26-000002
SEC(opens sec.gov)
Jun 264
Daniel Thomas O0001728117-25-000061
SEC(opens sec.gov)
Jun 64
Daniel Thomas O0001728117-24-000064
SEC(opens sec.gov)
Jun 94
Daniel Thomas O0001728117-23-000079
SEC(opens sec.gov)
Jul 154
Daniel Thomas O0001728117-22-000076
SEC(opens sec.gov)
Jun 304
Daniel Thomas O0000899243-22-024676
SEC(opens sec.gov)
Jun 104
Daniel Thomas O0001728117-21-000064
SEC(opens sec.gov)
Jun 34
Daniel Thomas O0000899243-21-021838
SEC(opens sec.gov)
May 174
Daniel Thomas O0001192482-21-000441
SEC(opens sec.gov)
Sep 304
Daniel Thomas O0001192482-20-000749
SEC(opens sec.gov)
Jun 184
Daniel Thomas O0001209191-20-037644
SEC(opens sec.gov)
Jun 94
Daniel Thomas O0000899243-20-015796
SEC(opens sec.gov)
Jun 274
Daniel Thomas O0000899243-19-018479
SEC(opens sec.gov)
Jun 114
Daniel Thomas O0000899243-19-016413
SEC(opens sec.gov)
Jun 114
Daniel Thomas O0001209191-19-036219
SEC(opens sec.gov)
Feb 124
Daniel Thomas O0001209191-19-009449
SEC(opens sec.gov)
Jan 284
Daniel Thomas O0000899243-19-002062
SEC(opens sec.gov)
Jun 274
Daniel Thomas O0000899243-18-018338
SEC(opens sec.gov)

Companies

Address

3115 MERRYFIELD ROW, SUITE 120

SAN DIEGO, CA, 92121